Kristin P Guilliams1, Melanie E Fields2, Dustin K Ragan3, Yasheng Chen3, Cihat Eldeniz4, Monica L Hulbert2, Michael M Binkley3, James N Rhodes3, Joshua S Shimony5, Robert C McKinstry5, Katie D Vo4, Hongyu An4, Jin-Moo Lee6, Andria L Ford7. 1. Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri; Department of Pediatrics, Washington University School of Medicine, Saint Louis, Missouri. 2. Department of Pediatrics, Washington University School of Medicine, Saint Louis, Missouri. 3. Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri. 4. Department of Radiology, Washington University School of Medicine, Saint Louis, Missouri. 5. Department of Pediatrics, Washington University School of Medicine, Saint Louis, Missouri; Department of Radiology, Washington University School of Medicine, Saint Louis, Missouri. 6. Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri; Department of Radiology, Washington University School of Medicine, Saint Louis, Missouri. Electronic address: leejm@wustl.edu. 7. Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri. Electronic address: forda@wustl.edu.
Abstract
BACKGROUND: Large-vessel vasculopathy (LVV) increases stroke risk in pediatric sickle cell disease beyond the baseline elevated stroke risk in this vulnerable population. The mechanisms underlying this added risk and its unique impact on the developing brain are not established. METHODS: We analyzed magnetic resonance imaging and angiography scans of 66 children with sickle cell disease and infarcts by infarct density heatmaps and Jacobian determinants, a metric utilized to delineate focal volume change, to investigate if infarct location, volume, frequency, and cerebral atrophy differed among hemispheres with and without LVV. RESULTS: Infarct density heatmaps demonstrated infarct "hot spots" within the deep white matter internal border zone region in both LVV and non-LVV hemispheres, but with greater infarct density and larger infarct volumes in LVV hemispheres (2.2 mL versus 0.25 mL, P < 0.001). Additional scattered cortical infarcts in the internal carotid artery territory occurred in LVV hemispheres, but were rare in non-LVV hemispheres. Jacobian determinants revealed greater atrophy in gray and white matter of the parietal lobes of LVV compared with non-LVV hemispheres. CONCLUSION: Large-vessel vasculopathy in sickle cell disease appears to increase ischemic vulnerability in the borderzone region, as demonstrated by the increased frequency and extent of infarction within deep white matter, and increased risk of focal atrophy. Scattered infarctions across the LVV-affected hemispheres suggest additional stroke etiologies of vasculopathy (i.e., thromboembolism) in addition to chronic hypoxia-ischemia.
BACKGROUND: Large-vessel vasculopathy (LVV) increases stroke risk in pediatric sickle cell disease beyond the baseline elevated stroke risk in this vulnerable population. The mechanisms underlying this added risk and its unique impact on the developing brain are not established. METHODS: We analyzed magnetic resonance imaging and angiography scans of 66 children with sickle cell disease and infarcts by infarct density heatmaps and Jacobian determinants, a metric utilized to delineate focal volume change, to investigate if infarct location, volume, frequency, and cerebral atrophy differed among hemispheres with and without LVV. RESULTS:Infarct density heatmaps demonstrated infarct "hot spots" within the deep white matter internal border zone region in both LVV and non-LVV hemispheres, but with greater infarct density and larger infarct volumes in LVV hemispheres (2.2 mL versus 0.25 mL, P < 0.001). Additional scattered cortical infarcts in the internal carotid artery territory occurred in LVV hemispheres, but were rare in non-LVV hemispheres. Jacobian determinants revealed greater atrophy in gray and white matter of the parietal lobes of LVV compared with non-LVV hemispheres. CONCLUSION: Large-vessel vasculopathy in sickle cell disease appears to increase ischemic vulnerability in the borderzone region, as demonstrated by the increased frequency and extent of infarction within deepwhite matter, and increased risk of focal atrophy. Scattered infarctions across the LVV-affected hemispheres suggest additional stroke etiologies of vasculopathy (i.e., thromboembolism) in addition to chronic hypoxia-ischemia.
Authors: Allison A King; John J Strouse; Mark J Rodeghier; Bruce E Compas; James F Casella; Robert C McKinstry; Michael J Noetzel; Charles T Quinn; Rebecca Ichord; Michael M Dowling; J Philip Miller; Michael R Debaun Journal: Am J Hematol Date: 2014-02 Impact factor: 10.047
Authors: Charles H Pegelow; Eric A Macklin; Franklin G Moser; Winfred C Wang; Jacqueline A Bello; Scott T Miller; Elliott P Vichinsky; Michael R DeBaun; Ludovico Guarini; Robert A Zimmerman; Donald P Younkin; Dianne M Gallagher; Thomas R Kinney Journal: Blood Date: 2002-04-15 Impact factor: 22.113
Authors: Monica L Hulbert; Robert C McKinstry; JoAnne L Lacey; Christopher J Moran; Julie A Panepinto; Alexis A Thompson; Sharada A Sarnaik; Gerald M Woods; James F Casella; Baba Inusa; Jo Howard; Fenella J Kirkham; Kofi A Anie; Jonathan E Mullin; Rebecca Ichord; Michael Noetzel; Yan Yan; Mark Rodeghier; Michael R Debaun Journal: Blood Date: 2010-10-12 Impact factor: 22.113
Authors: J M Fletcher; T P Bohan; M E Brandt; B L Brookshire; S R Beaver; D J Francis; K C Davidson; N M Thompson; M E Miner Journal: Arch Neurol Date: 1992-08
Authors: Kathleen J Helton; Robert J Adams; Karen L Kesler; Alex Lockhart; Banu Aygun; Catherine Driscoll; Matthew M Heeney; Sherron M Jackson; Lakshmanan Krishnamurti; Scott T Miller; Sharada A Sarnaik; William H Schultz; Russell E Ware Journal: Blood Date: 2014-06-09 Impact factor: 22.113
Authors: Hannah Song; Philip M Keegan; Suhaas Anbazhakan; Christian P Rivera; Yundi Feng; Victor O Omojola; Alexus A Clark; Shuangyi Cai; Jada Selma; Rudolph L Gleason; Edward A Botchwey; Yunlong Huo; Wenchang Tan; Manu O Platt Journal: Arterioscler Thromb Vasc Biol Date: 2020-03-12 Impact factor: 8.311
Authors: Kristin P Guilliams; Melanie E Fields; Dustin K Ragan; Cihat Eldeniz; Michael M Binkley; Yasheng Chen; Liam S Comiskey; Allan Doctor; Monica L Hulbert; Joshua S Shimony; Katie D Vo; Robert C McKinstry; Hongyu An; Jin-Moo Lee; Andria L Ford Journal: Blood Date: 2017-12-18 Impact factor: 22.113
Authors: Yaqiong Chai; Adam M Bush; Julie Coloigner; Aart J Nederveen; Benita Tamrazi; Chau Vu; Soyoung Choi; Thomas D Coates; Natasha Lepore; John C Wood Journal: Am J Hematol Date: 2019-02-21 Impact factor: 10.047
Authors: Soyoung Choi; Sharon H O'Neil; Anand A Joshi; Jian Li; Adam M Bush; Thomas D Coates; Richard M Leahy; John C Wood Journal: Am J Hematol Date: 2019-07-23 Impact factor: 10.047
Authors: Kristin P Guilliams; Fenella J Kirkham; Susanne Holzhauer; Steven Pavlakis; Bryan Philbrook; Catherine Amlie-Lefond; Michael J Noetzel; Nomazulu Dlamini; Mukta Sharma; Jessica L Carpenter; Christine K Fox; Marcela Torres; Rebecca N Ichord; Lori C Jordan; Michael M Dowling Journal: Stroke Date: 2019-05 Impact factor: 7.914
Authors: Derick Okwan-Duodu; Laura Hansen; Giji Joseph; Alicia N Lyle; Daiana Weiss; David R Archer; W Robert Taylor Journal: Arterioscler Thromb Vasc Biol Date: 2018-03-15 Impact factor: 8.311
Authors: Melanie E Fields; Kristin P Guilliams; Dustin Ragan; Michael M Binkley; Amy Mirro; Slim Fellah; Monica L Hulbert; Morey Blinder; Cihat Eldeniz; Katie Vo; Joshua S Shimony; Yasheng Chen; Robert C McKinstry; Hongyu An; Jin-Moo Lee; Andria L Ford Journal: Blood Date: 2019-03-11 Impact factor: 22.113
Authors: Melanie E Fields; Amy E Mirro; Kristin P Guilliams; Michael M Binkley; Luisa Gil Diaz; Jessica Tan; Slim Fellah; Cihat Eldeniz; Yasheng Chen; Andria L Ford; Joshua S Shimony; Allison A King; Hongyu An; Christopher D Smyser; Jin-Moo Lee Journal: Ann Neurol Date: 2020-09-16 Impact factor: 10.422